MedCap AB (publ) is a Swedish operating holding company focused on acquiring and developing small to medium-sized, market-leading niche companies in the life science sector, primarily in Northern Europe. The company operates through three distinct business areas: Assistive Tech, MedTech, and Specialty Pharma. The Assistive Tech segment, which is the largest revenue contributor, provides digital and physical aids for cognition, communication, environmental control, mobility, and orthopedics through subsidiaries such as Abilia, Swedelift, and Trident. The MedTech segment develops and sells medical technology products and services, including ECG systems (Cardiolex), carbon fiber components for medical imaging (Multi-Ply), and clean air systems for operating rooms (Toul Meditech and SurgiCube). The Specialty Pharma segment (Unimedic) develops and distributes registered, extemporaneous, and licensed medicines. MedCap's business model centers on long-term, active ownership. Rather than acting as a traditional private equity fund that seeks short-term exits, MedCap consolidates the revenues of its subsidiaries and works closely with their management teams to realize operational synergies and international expansion. The company generates the vast majority of its revenue from the manufacturing and sale of durable medical equipment and assistive devices, with the remainder coming from specialty pharmaceuticals. By targeting specialized, highly regulated niches with steady demand, MedCap maintains a strong competitive position and resilient margins across its portfolio.
